299 related articles for article (PubMed ID: 27703330)
21. Randomized, open-label, two-period crossover comparison of the pharmacokinetic and pharmacodynamic properties of two amlodipine formulations in healthy adult male Korean subjects.
Park JY; Kim KA; Lee GS; Park PW; Kim SL; Lee YS; Lee YW; Shin EK
Clin Ther; 2004 May; 26(5):715-23. PubMed ID: 15220015
[TBL] [Abstract][Full Text] [Related]
22. Pharmacokinetic and bioequivalence study of a fixed-dose combination of amlodipine besylate and rosuvastatin calcium compared to co-administration of separate tablets in healthy Korean subjects
.
Park JS; Jeon JY; Kim MG
Int J Clin Pharmacol Ther; 2019 Dec; 57(12):612-622. PubMed ID: 31549624
[TBL] [Abstract][Full Text] [Related]
23. Bioequivalence evaluation of two amlodipine salts, besylate and orotate, each in a fixed-dose combination with olmesartan in healthy subjects.
Lee SY; Kim JR; Jung JA; Huh W; Bahng MY; Ko JW
Drug Des Devel Ther; 2015; 9():2811-7. PubMed ID: 26082611
[TBL] [Abstract][Full Text] [Related]
24. Efficacy and tolerability of a fixed-dose combination of metoprolol extended release/amlodipine in patients with mild-to-moderate hypertension: a randomized, parallel-group, multicentre comparison with losartan plus amlodipine.
Pareek A; Chandurkar NB; Sharma R; Tiwari D; Gupta BS
Clin Drug Investig; 2010; 30(2):123-31. PubMed ID: 20067330
[TBL] [Abstract][Full Text] [Related]
25. Comparison of the pharmacokinetics and tolerability of HCP1004 (a fixed-dose combination of naproxen and esomeprazole strontium) and VIMOVO® (a marketed fixed-dose combination of naproxen and esomeprazole magnesium) in healthy volunteers.
Choi Y; Han H; Shin D; Lim KS; Yu KS
Drug Des Devel Ther; 2015; 9():4127-35. PubMed ID: 26257511
[TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetics and bioequivalence of fixed-dose combination of candesartan cilexetil/amlodipine besylate (16/10 mg) versus coadministration of individual formulations in healthy subjects.
Lee HW; Kang WY; Jung W; Gwon MR; Yang DH; Kim EH; Cho K; Yoon YR; Seong SJ
Transl Clin Pharmacol; 2020 Jun; 28(2):92-101. PubMed ID: 32656160
[TBL] [Abstract][Full Text] [Related]
27. Comparative pharmacokinetics of a fixed-dose combination vs concomitant administration of telmisartan and S-amlodipine in healthy adult volunteers.
Oh M; Park SE; Ghim JL; Choi YK; Shim EJ; Shin JG; Kim EY
Drug Des Devel Ther; 2017; 11():3543-3550. PubMed ID: 29270003
[TBL] [Abstract][Full Text] [Related]
28. Pharmacokinetic comparison between a fixed-dose combination of fimasartan/amlodipine/hydrochlorothiazide 60/10/25 mg and a corresponding loose combination of fimasartan/amlodipine 60/25 mg and hydrochlorothiazide 25 mg in healthy subjects.
Jung J; Lee S; Oh J; Lee S; Jang IJ; Lee D; Yu KS
Transl Clin Pharmacol; 2021 Mar; 29(1):53-64. PubMed ID: 33855001
[TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetic and pharmacodynamic characteristics of a new S-amlodipine formulation in healthy Korean male subjects: a randomized, open-label, two-period, comparative, crossover study.
Park JY; Kim KA; Park PW; Lee OJ; Ryu JH; Lee GH; Ha MC; Kim JS; Kang SW; Lee KR
Clin Ther; 2006 Nov; 28(11):1837-47. PubMed ID: 17213004
[TBL] [Abstract][Full Text] [Related]
30. Comparison of the efficacy and safety of fixed-dose amlodipine/losartan and losartan in hypertensive patients inadequately controlled with losartan: a randomized, double-blind, multicenter study.
Hong BK; Park CG; Kim KS; Yoon MH; Yoon HJ; Yoon JH; Yang JY; Choi YJ; Cho SY
Am J Cardiovasc Drugs; 2012 Jun; 12(3):189-95. PubMed ID: 22462558
[TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetic comparison of a fixed-dose combination versus concomitant administration of amlodipine, olmesartan, and rosuvastatin in healthy adult subjects.
Oh M; Shin JG; Ahn S; Kim BH; Kim JY; Shin HJ; Shin HJ; Ghim JL
Drug Des Devel Ther; 2019; 13():991-997. PubMed ID: 31114155
[No Abstract] [Full Text] [Related]
32. Pharmacokinetic drug-drug interaction assessment between LCZ696, an angiotensin receptor neprilysin inhibitor, and hydrochlorothiazide, amlodipine, or carvedilol.
Hsiao HL; Langenickel TH; Greeley M; Roberts J; Zhou W; Pal P; Rebello S; Rajman I; Sunkara G
Clin Pharmacol Drug Dev; 2015 Nov; 4(6):407-17. PubMed ID: 27137712
[TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetic and pharmacodynamic profiles of a fixed-dose combination of olmesartan medoxomil and amlodipine in healthy Chinese males and females.
Chen X; Hu P; Jiang J; Liu T; Zhong W; Liu H; Zhao Q
Clin Drug Investig; 2012 Dec; 32(12):783-90. PubMed ID: 23160920
[TBL] [Abstract][Full Text] [Related]
34. Investigation of bioequivalence of a new fixed-dose combination of acarbose and metformin with the corresponding loose combination as well as the drug-drug interaction potential between both drugs in healthy adult male subjects.
Kim S; Jang IJ; Shin D; Shin DS; Yoon S; Lim KS; Yu KS; Li J; Zhang H; Liu Y; Brendel E; Blode H; Wang Y
J Clin Pharm Ther; 2014 Aug; 39(4):424-31. PubMed ID: 24806030
[TBL] [Abstract][Full Text] [Related]
35. Pharmacodynamic (hemodynamic) and pharmacokinetic comparisons of S-amlodipine gentisate and racemate amlodipine besylate in healthy Korean male volunteers: two double-blind, randomized, two-period, two-treatment, two-sequence, double-dummy, single-dose crossover studies.
Kim BH; Kim JR; Kim MG; Kim KP; Lee BY; Jang IJ; Shin SG; Yu KS
Clin Ther; 2010 Jan; 32(1):193-205. PubMed ID: 20171424
[TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetic comparison of 2 fixed-dose combination tablets of amlodipine and valsartan in healthy male Korean volunteers: a randomized, open-label, 2-period, single-dose, crossover study.
Kim Y; Son M; Lee D; Roh H; Son H; Chae D; Bahng MY; Park K
Clin Ther; 2013 Jul; 35(7):934-40. PubMed ID: 23870605
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of the dose-response relationship of amlodipine and losartan combination in patients with essential hypertension: an 8-week, randomized, double-blind, factorial, phase II, multicenter study.
Park CG; Youn HJ; Chae SC; Yang JY; Kim MH; Hong TJ; Kim CH; Kim JJ; Hong BK; Jeong JW; Park SH; Kwan J; Choi YJ; Cho SY
Am J Cardiovasc Drugs; 2012 Feb; 12(1):35-47. PubMed ID: 22217192
[TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetics and bioequivalence study of irbesartan tablets after a single oral dose of 300 mg in healthy Thai volunteers.
Wittayalertpanya S; Chariyavilaskul P; Prompila N; Sayankuldilok N; Eiamart W
Int J Clin Pharmacol Ther; 2014 May; 52(5):431-6. PubMed ID: 24725445
[TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetics and bioequivalence study of a generic amlodipine tablet formulation in healthy male volunteers.
Sailer R; Arnold P; Erenmemişoğlu A; Martin W; Tamur U; Kanzik I; Hincal AA
Arzneimittelforschung; 2007; 57(7):462-6. PubMed ID: 17803059
[TBL] [Abstract][Full Text] [Related]
40. Pharmacokinetic Drug Interactions Between Amlodipine, Valsartan, and Rosuvastatin in Healthy Volunteers.
Seong SJ; Ohk B; Kang WY; Gwon MR; Kim BK; Cho S; Yang DH; Lee HW; Yoon YR
Adv Ther; 2019 Jul; 36(7):1642-1656. PubMed ID: 31119689
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
